News

Scientists have developed and received MHRA approval for a new device that could allow health professionals to test patients’ antibody response to COVID-19 in as little as seven minutes.

The virus that causes COVID-19 has many variants, and if scientists don’t stay on top of how it is changing in different parts of the world, testing for it may produce false negative results.

Researchers from Baylor College of Medicine have integrated whole-exome sequencing and targeted metabolomics to analyze the data of a group of 170 patients. They were pleased to find that the metabolomics data informed 44 percent of the cases.

A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research.

A national seroprevalence study concludes that 5% of the Spanish population has antibodies against SARS-CoV-2, no where near estimates thought to be required for the development of natural herd immunity.

A new study has shown that measurement of a fertility hormone can be accurately taken from a sample of human hair, opening up the possibility of a non-invasive test of ovarian reserve.

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

A new study published in the Journal of Dental Research demonstrates that testing of oropharyngeal secretions may reduce the number of false negative results from nasal swab testing of COVID-19 patients.

Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a new study from Karolinska Institutet.

Researchers have introduced a novel wearable device and set of data algorithms specifically tailored to catch early signs and symptoms and monitor the progression of COVID-19.